Directors’ Dealings | 24 November 2015 20:14

DGAP-DD: STRATEC Biomedical AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a service of EQS Group AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Last name: Siegle First name: Dr. Robert Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: STRATEC Biomedical AG / Registered Share ISIN/WKN of the financial instrument: DE000STRA555 Type of transaction: Sale Date: 23.11.2015 Price: 53.9813 Currency: EUR No. of items: 2256 Total amount traded: 121781.93 Place: Xetra Explanation for publication: Sale of remainder of shares by bank via Xetra marketplace in connection with recent exercising of 7,500 stock options; exercise price for underlying stock options: € 27.11 per stock option (c.f. directors’ dealings notification dated August 18, 2015). The shares thereby sold result from stock options granted as a component of compensation. Sale as follows: date / average price / average number of items / total amount traded — 20.11.2015 / EUR 54.0530 / 1,792.7245 / EUR 96,902.13 EUR — 23.11.2015 / EUR 53.7041 / 463.2755 / 24,879.79 EUR. Transaction closed. Information about the company with duty of publication Issuer: STRATEC Biomedical AG Gewerbestr. 37 75217 Birkenfeld Germany ISIN: DE000STRA555 WKN: STRA55 End of Directors’ Dealings Notification (c) DGAP 24.11.2015 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 23741